Quest Diagnostics to price senior notes via five bookrunners

By Devika Patel

Knoxville, Tenn., Dec. 9 – Quest Diagnostics Inc. is planning to sell senior notes, according to a 424B2 filed with the Securities and Exchange Commission.

The notes will have a make-whole call and then are callable at par.

J.P. Morgan Securities LLC, Morgan Stanley & Co. LLC, Wells Fargo Securities LLC, Goldman Sachs & Co. LLC and Mizuho Securities USA Inc. are the bookrunners.

Proceeds will be used to repay or redeem the company’s $500 million of 4.75% senior notes due 2020 at maturity and its $300 million of 2.5% senior notes due 2020 and for general corporate purposes.

The diagnostic testing company is based in Madison, N.J.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.